Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $13,448 | 12 | 51.3% |
| Travel and Lodging | $8,938 | 41 | 34.1% |
| Food and Beverage | $3,791 | 47 | 14.5% |
| Gift | $20.00 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $12,449 | 34 | $0 (2024) |
| Merck Sharp & Dohme LLC | $8,344 | 45 | $0 (2024) |
| PFIZER INC. | $3,676 | 15 | $0 (2021) |
| ModernaTX, Inc. | $1,728 | 7 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $5,876 | 7 | GlaxoSmithKline, LLC. ($3,841) |
| 2023 | $4,594 | 9 | GlaxoSmithKline, LLC. ($2,866) |
| 2022 | $2,776 | 3 | GlaxoSmithKline, LLC. ($2,741) |
| 2021 | $1,090 | 4 | Merck Sharp & Dohme Corporation ($1,070) |
| 2020 | $216.23 | 4 | Merck Sharp & Dohme Corporation ($216.23) |
| 2019 | $1,692 | 5 | PFIZER INC. ($1,692) |
| 2018 | $6,174 | 48 | Merck Sharp & Dohme Corporation ($3,865) |
| 2017 | $3,778 | 21 | GlaxoSmithKline, LLC. ($1,806) |
All Payment Transactions
101 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/14/2024 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $640.00 | General |
| 11/14/2024 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $640.00 | General |
| 11/05/2024 | Merck Sharp & Dohme LLC | — | Food and Beverage | In-kind items and services | $35.00 | General |
| Category: VACCINE | ||||||
| 10/28/2024 | Merck Sharp & Dohme LLC | — | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| Category: VACCINE | ||||||
| 08/29/2024 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $1,120.00 | General |
| 04/03/2024 | Merck Sharp & Dohme LLC | — | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| Category: VACCINE | ||||||
| 03/11/2024 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $1,441.44 | General |
| 10/27/2023 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $1,696.60 | General |
| 08/17/2023 | ModernaTX, Inc. | — | Travel and Lodging | In-kind items and services | $641.80 | General |
| 08/17/2023 | ModernaTX, Inc. | — | Food and Beverage | In-kind items and services | $534.54 | General |
| 08/17/2023 | ModernaTX, Inc. | — | Travel and Lodging | In-kind items and services | $206.72 | General |
| 08/17/2023 | ModernaTX, Inc. | — | Travel and Lodging | In-kind items and services | $174.93 | General |
| 08/17/2023 | ModernaTX, Inc. | — | Travel and Lodging | In-kind items and services | $90.39 | General |
| 08/17/2023 | ModernaTX, Inc. | — | Travel and Lodging | In-kind items and services | $50.00 | General |
| 08/17/2023 | ModernaTX, Inc. | — | Travel and Lodging | In-kind items and services | $30.00 | General |
| 01/19/2023 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $1,169.46 | General |
| 12/21/2022 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $1,580.79 | General |
| 08/08/2022 | Merck Sharp & Dohme LLC | — | Food and Beverage | In-kind items and services | $35.00 | General |
| Category: VACCINE | ||||||
| 03/03/2022 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $1,160.00 | General |
| 11/04/2021 | Merck Sharp & Dohme Corporation | GARDASIL 9 (Biological) | Food and Beverage | In-kind items and services | $35.00 | General |
| Category: VACCINE | ||||||
| 11/03/2021 | Merck Sharp & Dohme Corporation | GARDASIL 9 (Biological) | Food and Beverage | In-kind items and services | $35.00 | General |
| Category: VACCINE | ||||||
| 08/06/2021 | Merck Sharp & Dohme LLC | — | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| Category: VACCINE | ||||||
| 06/03/2021 | PFIZER INC. | — | Gift | In-kind items and services | $20.00 | General |
| 01/29/2020 | Merck Sharp & Dohme Corporation | GARDASIL 9 (Biological) | Travel and Lodging | Cash or cash equivalent | $82.34 | General |
| Category: VACCINE | ||||||
| 01/29/2020 | Merck Sharp & Dohme Corporation | GARDASIL 9 (Biological) | Food and Beverage | In-kind items and services | $49.60 | General |
| Category: VACCINE | ||||||
About Dr. Richard Rupp, MD
Dr. Richard Rupp, MD is a Adolescent Medicine healthcare provider based in Galveston, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/02/2006. The National Provider Identifier (NPI) number assigned to this provider is 1700893625.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Richard Rupp, MD has received a total of $26,197 in payments from pharmaceutical and medical device companies, with $5,876 received in 2024. These payments were reported across 101 transactions from 4 companies. The most common payment nature is "Consulting Fee" ($13,448).
Practice Information
- Specialty Adolescent Medicine
- Location Galveston, TX
- Active Since 08/02/2006
- Last Updated 07/08/2007
- Taxonomy Code 2080A0000X
- Entity Type Individual
- NPI Number 1700893625
Products in Payments
- V181 (Biological) $1,337
- MK-1654 (Drug) $1,272
- V160 (Biological) $1,257
- V114 (Biological) $1,123
- PREVNAR - 13 (Biological) $1,041
- GARDASIL 9 (Biological) $286.23
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.